Name: SAB Biotherapeutics, Inc. (SABS) Balance Sheet
Creator: FinSpry

SAB Biotherapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for SAB Biotherapeutics, Inc. (SABS) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	8.90	56.57	15.05	33.21	12.61
Short-Term Investments	11.86	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	20.76	56.57	15.05	33.21	12.61
Accounts Receivable	0.05	0.00	5.56	8.01	20.57
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	2.98	2.34	1.49	4.15	1.28
Total Current Assets	23.79	58.91	22.10	50.19	34.46
Non-Current Assets
Property, Plant & Equipment (Net)	19.92	24.68	28.34	30.95	22.08
Other Non-Current Assets	0.22	0.35	0.47	0.00	0.00
Total Non-Current Assets	20.40	5.30	28.81	30.95	0.00
Total Assets	44.20	83.94	50.90	81.14	56.54
Current Liabilities
Accounts Payable	1.69	0.95	3.68	16.91	7.38
Short-Term Debt	0.28	1.05	0.77	1.80	0.54
Current Portion of Long-Term Debt	0.28	1.05	0.77	1.80	0.54
Accrued Liabilities	4.99	6.69	3.50	4.78	1.28
Deferred Revenue	0.00	1.32	0.00	0.10	0.10
Other Current Liabilities	5.47	0.00	0.09	6.34	0.64
Total Current Liabilities	7.98	10.81	14.99	26.46	11.06
Non-Current Liabilities
Long-Term Debt	3.86	4.05	0.54	5.42	0.17
Other Non-Current Liabilities	6.39	11.77	0.32	6.34	0.00
Total Non-Current Liabilities	10.25	15.83	4.85	22.47	0.00
Total Liabilities	18.23	26.64	19.85	42.59	17.53
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-124.17	-90.06	-47.87	-29.13	-11.98
Accumulated Other Comprehensive Income	-0.14	0.03	0.00	0.00	0.00
Treasury Stock	5.52	-5.52	5.52	0.00	0.00
Additional Paid-in Capital	155.79	152.86	84.45	67.67	0.00
Shares Outstanding	9.29	9.23	5.04	4.35	0.00
Total Stockholders' Equity	25.97	57.30	31.06	38.55	39.01
Total Liabilities & Equity	44.20	83.94	50.90	81.14	0.00